Taken together, our data suggest that co-administration of DNA encoding CD40L with antigen-specific DNA vaccine were able to enhance antigen-specific CD8+ T cell against endogenous tumor antigen but not foreign tumor antigen. Here, CD8A is linked to neoplasm.